Emanuel F. Petricoin
Founder at Ceres Nanosciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ross M. Dunlap | M | - |
Ceres Nanosciences, Inc.
 Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | - |
| Lance Liotta | M | - |
Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | - |
| Nils Bergenhem | M | 65 |
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 13 years |
| M. Young | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 10 years |
| Scott Gazelle | M | - |
Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | - |
| Andrew Black | M | - |
Perthera, Inc.
 Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
| Nancy Emrick | F | - |
Perthera, Inc.
Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
| Stephan Vagner | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Adrian Schwarzer | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Matthew Fury | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Ian Wright | M | - |
Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | - |
| Rob Walker | M | - |
Perthera, Inc.
Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
| Thomas Miller | M | - |
Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | - |
| Lionel Goldfrank | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 10 years |
| William T. Nolan | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 9 years |
| Arshad Siddiqui | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 11 years |
| Jack Daiss | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Rainer Fuchs | M | - |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 12 years |
| Jack Fuchs | M | - |
Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA. | 6 years |
| Charles K. Nicholas | M | - |
University of Maryland
| 36 years |
| Yehuda Neuberger | M | 47 |
Perthera, Inc.
Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
| William Lee | M | - |
Perthera, Inc.
Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
| John T. Reid | M | 84 |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | 12 years |
| Einaras Gravrock | M | - |
Perthera, Inc.
Perthera, Inc. Medical/Nursing ServicesHealth Services Perthera, Inc. provides personalized medicine in treatment of cancer patients. The firm offers multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient’s unique cancer. The company was founded by Dendy M. Young and Emanuel F. Petricoin III and is headquartered in McLean, VA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Donald C. Fresne | M | 96 |
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | - |
| Michael S. Klassen | M | - |
University of Maryland
| 8 years |
| Matt Snowling | M | - |
University of Maryland
| 9 years |
| Andrew Gerber | M | 56 |
University of Maryland
| 8 years |
| ElRoy Amitzur | M | - |
University of Maryland
| 6 years |
| Irwin Chen | M | - |
University of Maryland
| 3 years |
| Rajiv Laroia | M | 61 |
University of Maryland
| 4 years |
| Kamil Yilmaz | M | - |
University of Maryland
| 5 years |
| Shai Schiller | M | - |
University of Maryland
| 7 years |
| Qi Li | M | 61 |
University of Maryland
| 5 years |
| Qiang Yang | M | 62 |
University of Maryland
| 3 years |
| Yagyensh Pati | M | 60 |
University of Maryland
| 5 years |
| Sanjay Shukla | M | 52 |
University of Maryland
| 5 years |
| Theresa Alfaro Daytner | F | - |
University of Maryland
| 4 years |
| Steven D. List | M | - |
University of Maryland
| 4 years |
| David Steinberg | M | - |
University of Maryland
| 4 years |
| Scott C | M | - |
University of Maryland
| 5 years |
| Michael Kushin | M | - |
University of Maryland
| 4 years |
| Lin Lin Zhou | M | 63 |
University of Maryland
| 3 years |
| Hai Ying Zhao | M | 59 |
University of Maryland
| 3 years |
| Evan Wolff | M | - |
University of Maryland
| 5 years |
| David Crabtree | M | - |
University of Maryland
| 4 years |
| David H. Jung | M | - |
University of Maryland
| 4 years |
| Mark D. Geller | M | - |
University of Maryland
| 4 years |
| Nicole G. Minnick | F | - |
University of Maryland
| 4 years |
| Rich Luxenberg | M | - |
University of Maryland
| 4 years |
| Curtis Ervin | M | - |
University of Maryland
| 4 years |
| Greg A. Carter | M | - |
University of Maryland
| 4 years |
| Tony V. Steelman | M | - |
University of Maryland
| 4 years |
| Tabetha A. Baume-Chandler | F | - |
University of Maryland
| 4 years |
| Rick Harrison | M | - |
University of Maryland
| 4 years |
| Peter X Huang | M | - |
University of Maryland
| 4 years |
| Joseph M. Wrobleski | M | - |
University of Maryland
| 4 years |
| Brian L. Katz | M | - |
University of Maryland
| 4 years |
| Dave W. McClarin | M | - |
University of Maryland
| 4 years |
| Shawn M. Ruehl | M | - |
University of Maryland
| 4 years |
| Yvette M. Golladay | F | - |
University of Maryland
| 5 years |
| Eugene Bredow | M | 54 |
University of Maryland
| 4 years |
| Steve Sarnecki | M | - |
University of Maryland
| 4 years |
| Hiran Anthony Cabraal | M | - |
University of Maryland
| 4 years |
| Darrel L. Williams | M | - |
University of Maryland
| 3 years |
| Mark P. Elless | M | - |
University of Maryland
| 3 years |
| Dale Fuller | M | - |
University of Maryland
| 4 years |
| Christopher Hearing | M | 61 |
University of Maryland
| 2 years |
| Caroline S. Pisano | F | 57 |
University of Maryland
| 3 years |
| Peter R. Culpepper | M | 64 |
University of Maryland
| 2 years |
| John J. Carbone | M | 62 |
University of Maryland
| 3 years |
| Jill Taymans | F | 55 |
University of Maryland
| 4 years |
| Adam I. Friedman | M | - |
University of Maryland
| 4 years |
| Eugene I. Maddred | M | - |
University of Maryland
| 4 years |
| Martin Friedman | M | 73 |
University of Maryland
| 3 years |
| Thomas David Teles | M | - |
University of Maryland
| 4 years |
| Robert Adams Noyes | M | 55 |
University of Maryland
| 4 years |
| Farukh Z. Farooqi | M | - |
University of Maryland
| 4 years |
| John E. Brennan | M | - |
University of Maryland
| 4 years |
| Peter Yared | M | - |
University of Maryland
| 6 years |
| Kevin Smith | M | - |
University of Maryland
| 4 years |
| Robert W. Henley | M | 57 |
University of Maryland
| 4 years |
| Scott Needleman | M | - |
University of Maryland
| 4 years |
| Matt Theurer | M | - |
University of Maryland
| 4 years |
| Gregory Hearne | M | - |
University of Maryland
| 4 years |
| Jonathan Gustave | M | - |
University of Maryland
| 4 years |
| Kamlesh Miller | F | - |
University of Maryland
| 4 years |
| H. Huss | M | 73 |
University of Maryland
| 6 years |
| Allan Michael Budelman | M | - |
University of Maryland
| 4 years |
| Jeffrey Greenberg | M | - |
University of Maryland
| 4 years |
| Steven H. Krein | M | - |
University of Maryland
| 4 years |
| Ajoy Mallik | M | - |
University of Maryland
| 4 years |
| Marc Blazer | M | - |
University of Maryland
| 4 years |
| Andrea L. Nicolas | M | - |
University of Maryland
| 4 years |
| Frank Taylor Shull | M | - |
University of Maryland
| 4 years |
| Carol Anne Huff | F | - |
University of Maryland
| 3 years |
| Cindy Rose Quackenbush | F | - |
University of Maryland
| 4 years |
| Stuart Schwartz | M | - |
University of Maryland
| 4 years |
| Edmond Sanctis | M | - |
University of Maryland
| 5 years |
| Qin Si Zhao | M | 60 |
University of Maryland
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Emanuel F. Petricoin
- Personal Network
